SMTI · Sanara MedTech Inc.
$34.05
+0.19 (+0.56%)
At close · Aug 3
Market Cap
$310.29M
Shares
9.16M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$33.86
Open$33.63
Day$33.62–34.00
52W$16.05–35.95
Avg vol 30d201K
Short int378K · 4.1% float · 7.2d
Short vol33%
Last earningsMay 11, 2026
DataJan 2020–Jul 2026
Filing10-Q · May 12
Up next
Next earnings call
Aug 10, 2026
Est · unconfirmed
· in 1 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 12, 2026
AI Brief
TL;DR.
Bullish
Bearish
From the call
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Ask ALVIS about this →Equibles Rating
blended score · not investment adviceOverall
Neutral
SellHoldBuy
Technical
Buy
Momentum
Very Strong
Sentiment
Neutral
Fundamentals
Strong
Quant / Vol
Very High
Market backdrop
VIX 16 · calm
Equity put/call 0.63
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+51%
above
Price vs 50-day avg
+41%
above
RSI (14)
83
overbought
MACD trend
Positive
52-week position
89%
near high
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
+36%
trailing
6-month return
+67%
trailing
YTD return
+45%
this year
Relative strength
+59%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $24 › 200d $22 — 50d above 200d
Institutional flow
Distributing
13 of 65 funds reported for Jun 30 · net -16.2K sh shares · +2 new
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
4.12% of float · ▲ +4.4% MoM · 7.2 days cover
Volume signal
Reversal watch
High volume on a down day — possible exhaustion
Institution breadth
Multi-yr high
65 holders — near 3-yr high, broad support
Squeeze score
93
high risk · 0–100
Fundamentals
Revenue growth
+32%
Y/Y
Gross margin
613%
contracting
EPS growth
−282%
Y/Y
Free cash flow
$2.2M
Balance sheet
$29.4M
net debt
Quant / Vol
risk profile
Volatility
65%
annualized · 1-yr
Max drawdown
−54%
past year
ATR
4.7%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Latest guidance
· from the 8-K filed May 11, 2026
second quarter of 2026
Net revenue
Maintained
$28.5M – $29.5M
prior qtr $27.8M
midpoint +4.3% QoQ
full year ending December 31, 2026
Net revenue
Maintained
$116M – $121M
prior FY $103.12M
midpoint +14.9% Y/Y
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+51%
Bullish
Price vs 50-day avg
+41%
Bullish
RSI (14)
83
Bearish
MACD trend
Positive
Bullish
52-week position
89%
Bullish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross)
No cross
50d $24 › 200d $22 — 50d above 200d
Institutional flow
Distributing
13 of 65 funds reported for Jun 30 · net -16.2K sh shares · +2 new
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
4.12% of float · ▲ +4.4% MoM · 7.2 days cover
Volume signal
Reversal watch
High volume on a down day — possible exhaustion
Institution breadth
Multi-yr high
65 holders — near 3-yr high, broad support
Price context
position in its 52-week range
52-wk low $16
Now $34 · 89%
52-wk high $36
vs 200-day avg +51%
vs 50-day avg +41%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from its earnings releases, calls, and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted EBITDA non-GAAP | $4.3M | first quarter of 2026 | — |
|
|
|||
| Sales reps | 43 | first quarter of 2026 | — |
| Cash from operating activities | $6.8M | FY2025 | — |
| Adjusted Net Revenue (excluding BIASURGE sales) non-GAAP | $102.7M | Twelve Months Ended December 31, 2025 (Low) | — |
Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file
Versus peers
Medical Instruments & Supplies — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
SMTI
this stock
Sanara MedTech Inc.
|
$310.29M | +45.0% | +32.5% | — | 4.1% |
|
ISRG
Intuitive Surgical Inc
|
$124.82B | -37.6% | +20.5% | 40.6 | 1.9% |
|
MDLN
Medline Inc.
|
$51.60B | -6.5% | +11.5% | — | 2.2% |
|
BDX
Becton Dickinson & Co
|
$45.64B | +10.0% | +8.2% | 62.9 | 3.8% |
|
ALC
Alcon Inc
|
$33.62B | -12.5% | +10.5% | — | 2.7% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| SMTI | +32.5% | +36.3% | +67.3% | +43.5% | +45.0% |
| SPY | +1.1% | +0.3% | +8.2% | +0.0% | +9.6% |
| vs SPY | +31.4% | +36.0% | +59.1% | +43.5% | +35.5% |
Key facts
CIK
714256
CUSIP
79957L100
13F (30d)
14 filings
14 filers
Visit website
Investor relations